Literature DB >> 25501279

PCAF-mediated Akt1 acetylation enhances the proliferation of human glioblastoma cells.

Shuguang Zhang1, Guan Sun, Zhimin Wang, Yi Wan, Jun Guo, Lei Shi.   

Abstract

Glioblastoma is the most aggressive malignant primary brain tumor in humans. The activation of PI3K/Akt1 signaling pathway is involved in the proliferation of glioblastoma; however, the underlying mechanism of Akt1 activation during the development of glioblastoma remains largely unclear. Recently, the modification of molecular molecules at protein level such as acetylation has been shown to be related to the function of these molecules. Thus, in our present studies, the acetylation of Akt1 molecule and its role in the proliferation of glioblastoma cells was explored. The results showed that Akt1 was markedly acetylated in glioblastoma cells compared to normal human astrocytes. Mechanistically, PCAF-mediated Akt1 acetylation enhanced Akt1 phosphorylation at both sites of Thr(308) and Ser(473) and further promoted the proliferation of glioblastoma cells. Together, these data implicate that, as a post-translational regulation, PCAF-mediated Akt1 acetylation plays an important role in the proliferation of human glioblastoma, suggesting a novel target for clinical application.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25501279     DOI: 10.1007/s13277-014-2522-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  43 in total

1.  Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16.

Authors:  Tuo Li; Benjamin A Diner; Jin Chen; Ileana M Cristea
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-12       Impact factor: 11.205

2.  Sublytic C5b-9 complexes induce proliferative changes of glomerular mesangial cells in rat Thy-1 nephritis through TRAF6-mediated PI3K-dependent Akt1 activation.

Authors:  Wen Qiu; Yan Zhang; Xiaomei Liu; Jianbo Zhou; Yan Li; Ying Zhou; Kai Shan; Mei Xia; Nan Che; Xuefeng Feng; Dan Zhao; Yingwei Wang
Journal:  J Pathol       Date:  2011-12-09       Impact factor: 7.996

3.  TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K63-linked ubiquitination.

Authors:  Jie Yan; Qi Li; Ai-Ping Mao; Ming-Ming Hu; Hong-Bing Shu
Journal:  J Mol Cell Biol       Date:  2014-04       Impact factor: 6.216

4.  Forced downregulation of RACK1 inhibits glioma development by suppressing Src/Akt signaling activity.

Authors:  Renjun Peng; Bing Jiang; Jianrong Ma; Zhiming Ma; Xin Wan; Hongwei Liu; Zigui Chen; Quan Cheng; Rui Chen
Journal:  Oncol Rep       Date:  2013-09-06       Impact factor: 3.906

5.  The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60.

Authors:  Jagruti H Patel; Yanping Du; Penny G Ard; Charles Phillips; Beth Carella; Chi-Ju Chen; Carrie Rakowski; Chandrima Chatterjee; Paul M Lieberman; William S Lane; Gerd A Blobel; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

6.  Inhibition of the Jagged/Notch pathway inhibits retinoblastoma cell proliferation via suppressing the PI3K/Akt, Src, p38MAPK and Wnt/β‑catenin signaling pathways.

Authors:  Wei Xiao; Xiaoyun Chen; Mingguang He
Journal:  Mol Med Rep       Date:  2014-05-06       Impact factor: 2.952

7.  Properties and evaluation of quaternized chitosan/lipid cation polymeric liposomes for cancer-targeted gene delivery.

Authors:  Xiaofei Liang; Xiaoyu Li; Jin Chang; Yourong Duan; Zonghai Li
Journal:  Langmuir       Date:  2013-06-27       Impact factor: 3.882

8.  The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma Cells In Vitro.

Authors:  Ha-Yon Kim; Ji-Young Hwang; Seong-Woo Kim; Hyo-Jin Lee; Hwan-Jung Yun; Samyong Kim; Deog-Yeon Jo
Journal:  Cancer Res Treat       Date:  2010-12-31       Impact factor: 4.679

Review 9.  Standards of care and novel approaches in the management of glioblastoma multiforme.

Authors:  Andreas F Hottinger; Roger Stupp; Krisztian Homicsko
Journal:  Chin J Cancer       Date:  2014-01

10.  Inhibition of STAT3 reduces astrocytoma cell invasion and constitutive activation of STAT3 predicts poor prognosis in human astrocytoma.

Authors:  Qinchuan Liang; Chenkai Ma; Yang Zhao; Guodong Gao; Jie Ma
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

View more
  7 in total

Review 1.  KATapulting toward Pluripotency and Cancer.

Authors:  Calley L Hirsch; Jeffrey L Wrana; Sharon Y R Dent
Journal:  J Mol Biol       Date:  2016-10-06       Impact factor: 5.469

Review 2.  Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis.

Authors:  Mariam Markouli; Dimitrios Strepkos; Kostas A Papavassiliou; Athanasios G Papavassiliou; Christina Piperi
Journal:  Cancers (Basel)       Date:  2022-05-27       Impact factor: 6.575

3.  Carnosol Is a Novel Inhibitor of p300 Acetyltransferase in Breast Cancer.

Authors:  Halima Alsamri; Hussain El Hasasna; Bincy Baby; Aysha Alneyadi; Yusra Al Dhaheri; Mohammed Akli Ayoub; Ali H Eid; Ranjit Vijayan; Rabah Iratni
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

4.  Loss of Elp3 Impairs the Acetylation and Distribution of Connexin-43 in the Developing Cerebral Cortex.

Authors:  Sophie Laguesse; Pierre Close; Laura Van Hees; Alain Chariot; Brigitte Malgrange; Laurent Nguyen
Journal:  Front Cell Neurosci       Date:  2017-05-01       Impact factor: 5.505

5.  IL-17A promotes the proliferation of human nasopharyngeal carcinoma cells through p300-mediated Akt1 acetylation.

Authors:  Kemin Cai; Bing Wang; Hongmei Dou; Ronglan Luan; Xueli Bao; Jiusheng Chu
Journal:  Oncol Lett       Date:  2017-03-31       Impact factor: 2.967

6.  Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells.

Authors:  Evangelia A Koutsogiannouli; Nicholas Wagner; Christiane Hader; Maria Pinkerneil; Michèle J Hoffmann; Wolfgang A Schulz
Journal:  Int J Mol Sci       Date:  2017-07-05       Impact factor: 5.923

7.  Lysine Acetyltransferase 2B predicts favorable prognosis and functions as anti-oncogene in cervical carcinoma.

Authors:  Lei Li; Juntao Zhang; Shuping Cao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.